Literature DB >> 8784134

Potentiation of oxygen-glucose deprivation-induced neuronal death after induction of iNOS.

S J Hewett1, J K Muir, D Lobner, A Symons, D W Choi.   

Abstract

BACKGROUND AND
PURPOSE: Previous studies have shown that brain ischemia and other insults can induce a marked increase in inducible nitric oxide synthase (iNOS) expression in astrocytes and some immune cells, but the biological significance of this phenomenon has not been elucidated. The purpose of the present study was to determine whether this induction of astrocyte iNOS alters neuronal vulnerability to severe hypoxic insults.
METHODS: Astrocytic iNOS was induced by exposure of murine cortical cultures to interferon gamma in combination with either interleukin-1 beta or lipopolysaccharide. Cultures were exposed to combined oxygen-glucose deprivation. The extracellular concentration of glutamate was measured by high-performance liquid chromatography. N-Methyl-D-aspartate (NMDA) receptor activity was assessed by measurement of 45Ca2+ influx: neuronal death was assessed by morphological examination and quantitated by measurement of lactate dehydrogenase efflux to the bathing medium.
RESULTS: In murine neocortical cell cultures containing neurons and astrocytes, neuronal injury induced by combined oxygen-glucose deprivation was not reduced by the addition of the nitric oxide synthase inhibitors NG-nitro-L-arginine or LG-nitro-arginine methyl ester. However, after induction of astrocyte iNOS activity with interferon gamma plus lipopolysaccharide or interleukin-1 beta, oxygen-glucose deprivation-induced neuronal injury was markedly enhanced and nitric oxide synthase inhibitors became protective. This iNOS-mediated potentiation was associated with a large increase in both extracellular glutamate accumulation and 45Ca2+ influx into neurons. The potentiation could be blocked by MK-801 but not CNQX, suggesting critical involvement of NMDA receptor activation.
CONCLUSIONS: These results support the idea that nitric oxide production mediated by induced astrocytic iNOS can potentiate NMDA receptor-mediated neuronal death consequent to hypoxic-ischemic insults.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8784134     DOI: 10.1161/01.str.27.9.1586

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  14 in total

Review 1.  Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1.

Authors:  G L Semenza
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Changes of nitric oxide and its relationship with clinical features, intracranial pressure and outcome in acute head injury.

Authors:  D Zhou; M Qiu; Y Guan; L Li
Journal:  J Tongji Med Univ       Date:  2000

Review 3.  The inflammatory response in stroke.

Authors:  Qing Wang; Xian Nan Tang; Midori A Yenari
Journal:  J Neuroimmunol       Date:  2006-12-26       Impact factor: 3.478

Review 4.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

5.  Inducible nitric oxide synthase provides protection against injury-induced thrombosis in female mice.

Authors:  Rita K Upmacis; Hao Shen; Lea Esther S Benguigui; Brian D Lamon; Ruba S Deeb; Katherine A Hajjar; David P Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-20       Impact factor: 4.733

Review 6.  Reactive astrocytes as therapeutic targets for CNS disorders.

Authors:  Mary E Hamby; Michael V Sofroniew
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

7.  Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene.

Authors:  C Iadecola; F Zhang; R Casey; M Nagayama; M E Ross
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

8.  TGF beta 1 and TNF alpha potentiate nitric oxide production in astrocyte cultures by recruiting distinct subpopulations of cells to express NOS-2.

Authors:  Mary E Hamby; Ariel R Gragnolati; Sandra J Hewett; James A Hewett
Journal:  Neurochem Int       Date:  2007-10-18       Impact factor: 3.921

Review 9.  Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.

Authors:  J Y Kim; M Kawabori; M A Yenari
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

10.  Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia.

Authors:  R Chavez-Valdez; L J Martin; D L Flock; F J Northington
Journal:  Neuroscience       Date:  2012-05-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.